Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.84 USD | -0.87% | -4.87% | -6.76% |
Financials (USD)
Sales 2024 * | 45.83B | Sales 2025 * | 46.34B | Capitalization | 96.96B |
---|---|---|---|---|---|
Net income 2024 * | -3.95B | Net income 2025 * | 10.31B | EV / Sales 2024 * | 2.96 x |
Net Debt 2024 * | 38.57B | Net Debt 2025 * | 30.42B | EV / Sales 2025 * | 2.75 x |
P/E ratio 2024 * |
-32.9
x | P/E ratio 2025 * |
8.7
x | Employees | 34,100 |
Yield 2024 * |
5.06% | Yield 2025 * |
5.28% | Free-Float | 69.13% |
Latest transcript on Bristol-Myers Squibb Company
1 day | -0.87% | ||
1 week | -4.87% | ||
Current month | -11.78% | ||
1 month | -8.60% | ||
3 months | -4.28% | ||
6 months | -16.61% | ||
Current year | -6.76% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 15-01-31 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 19-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 16-03-31 |
Derica Rice
BRD | Director/Board Member | 59 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.97% | 215 M€ | +12.15% | - | |
4.99% | 2 M€ | -.--% | ||
4.01% | 18 M€ | +2.91% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 47.84 | -0.87% | 11,763,053 |
24-04-16 | 48.26 | -0.52% | 11,931,277 |
24-04-15 | 48.51 | +0.48% | 11,943,603 |
24-04-12 | 48.28 | -1.71% | 12,459,210 |
24-04-11 | 49.12 | -2.33% | 11,781,039 |
Delayed Quote Nyse, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.76% | 96.96B | |
+28.79% | 676B | |
+25.15% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.13% | 210B | |
-0.25% | 204B | |
-9.73% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- BMY Stock